RS

Robert Simon

North America, California, United States, San Francisco

Description

Robert Simon is the Sr. Managing Partner, IT Venture Fund at BDC.

Investor Profile

Robert Simon has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in Canada.
  • Strong thematic focus on Biotechnology, Medical, Therapeutics.

Stage Focus

  • Series A (100%)

Country Focus

  • Canada (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Robert Simon frequently co-invest with?

Fonds de solidarité FTQ
North America, Quebec, Canada, Montréal
Co-Investments: 1
Northleaf Capital Partners
North America, Ontario, Canada, Toronto
Co-Investments: 1
BDC Healthcare Venture
North America, Quebec, Canada, Montréal
Co-Investments: 1
Celgene
North America, New Jersey, United States, Summit
Co-Investments: 1
Lumira Ventures
North America, Ontario, Canada, Toronto
Co-Investments: 1
BDC Venture Capital
North America, Alberta, Canada, Calgary
Co-Investments: 1
MN
North America, New York, United States, New York
Co-Investments: 1
CTI Life Sciences Fund
North America, Quebec, Canada, Montréal
Co-Investments: 1
Brace Pharma
North America, Maryland, United States, Rockville
Co-Investments: 1
Eli Lilly
North America, Indiana, United States, Indianapolis
Co-Investments: 1

What are some of recent deals done by Robert Simon?

Zymeworks

Vancouver, British Columbia, Canada

Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.

BiotechnologyMedicalTherapeutics
Series AJan 8, 2016
Amount Raised: $61,500,000